Kewaunee Scientific Corporation · NASDAQ:KEQU
Kewaunee Scientific — Shareholder Meeting (August 2021)
25 slides from Kewaunee Scientific's shareholder meeting presentation, Aug 24, 2021
Slide 1: Kewaunee Scientific Corporation
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide 1
Slide 2: Special Note Regarding Forward-Looking Statements
Special Note Regarding Forward-Looking Statements Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements other than statements of historical fact included in this docume
Slide 3: Agenda
Agenda • Kewaunee Scientific Overview • Fiscal Year 2021 Review • Outlook and Strategic Direction • Q&A Kewaunee Scientific Corporation | NASDAQ: KEQU 3
Slide 4: Kewaunee Scientific Overview
Kewaunee Scientific Overview Kewaunee Scientific Corporation | NASDAQ: KEQU 4
Slide 5: Illustrative End-Users
Kewaunee Scientific Overview Kewaunee is a leading global designer, manufacturer, and installer of specialized equipment and technical furniture products for laboratories across an array of industries, including life sciences, education, government, healthcare, and general research end-markets. Stat
Slide 6: Kewaunee Scientific Overview
Kewaunee Scientific Overview The industries served by Kewaunee continue to receive prioritization for investment dollars as companies, governments, and institutions look to encourage discovery that is dependent on continued investment in research and development spaces. Market Sectors Actual Project
Slide 7: Kewaunee Scientific Overview
Kewaunee Scientific Overview Kewaunee Scientific Corporation | NASDAQ: KEQU 7
Slide 8: Kewaunee Scientific Overview
Kewaunee Scientific Overview HEALTHCARE Kewaunee is active in • Market includes hospitals, surgery centers, testing centers, elderly care communities, etc. multiple sectors, • Macro population and aging trends support continued investment in health related initiatives requiring providing geographica
Slide 9: Kewaunee Scientific Overview
Kewaunee Scientific Overview Kewaunee is a North American leader in manufactured laboratory, healthcare, and technical furniture. Domestically, the company primarily relies on its dealer and distribution network to sell its products to end users. Designs, manufactures, and installs laboratory, healt
Slide 10: Kewaunee Scientific Overview
Kewaunee Scientific Overview Internationally, Kewaunee participates throughout the entire laboratory build and operate value chain from pre-construction through post-construction with market leading positions in India and the Middle East Turn-key provider of total laboratory solution – Current Inter
Slide 11: FY 2021 Review
FY 2021 Review Kewaunee Scientific Corporation | NASDAQ: KEQU 11
Slide 12: FY 2021 Review – Consolidated Results
FY 2021 Review – Consolidated Results Sales EBITDA* ($ in millions) ($ in millions) $180 $5.0 $4.2 $150 $4.0 $147 $148 $147 $120 $3.0 $90 $2.0 $60 $1.0 $30 $0.2 $(0.2) $- $- FY19 FY20 FY21 FY19 FY20 FY21 $(1.0) Net Earnings (Loss) Diluted EPS ($ in millions) $1.00 $2 $0.50 $1 $2 $0.55 $- $- FY19 FY2
Slide 13: FY 2021 Review – Domestic Segment
FY 2021 Review – Domestic Segment The Domestic market was greatly impacted by delays in project decisions, the inability to access project sites and an overall slowdown related to the COVID-19 pandemic. Domestic Sales Domestic Net Earnings and EBITDA* ($ in thousands) ($ in thousands) $140,000 $8,00
Slide 14: FY 2021 Review – International Segment
FY 2021 Review – International Segment International segment delivered strong performance despite widespread government mandated shutdowns in all the markets where they compete. International Sales International Net Earnings and EBITDA* ($ in thousands) ($ in thousands) $40,000 $3,500 $3,164 $2,965
Slide 15: FY 2021 Review – Other Accomplishments
FY 2021 Review – Other Accomplishments Kewaunee’s Associates did not let COVID-19 slow down efforts to improve the Company’s positioning in the market-place. Kewaunee Scientific Corporation | NASDAQ: KEQU 15
Slide 16: Strategic Direction and Outlook
Strategic Direction and Outlook Kewaunee Scientific Corporation | NASDAQ: KEQU 16
Slide 17: Strategic Direction and Outlook
Strategic Direction and Outlook Kewaunee Scientific Corporation | NASDAQ: KEQU 17
Slide 18: To be the global supplier of choice with customers in the laboratory furniture and infrastructure markets
Strategic Direction and Outlook “To be the global supplier of choice with customers in the laboratory furniture and infrastructure markets.” Kewaunee Scientific Corporation | NASDAQ: KEQU 18
Slide 19: Outlook and Strategic Vision
Outlook and Strategic Vision Our Guiding Principles We will be easy to do business with We will get closer to our customer(s) We will do everything with excellence We will lead and not follow (we are innovators) Kewaunee Scientific Corporation | NASDAQ: KEQU 19
Slide 20: Strategic Direction and Outlook
Strategic Direction and Outlook Kewaunee Scientific Corporation | NASDAQ: KEQU 20
Slide 21: Kewaunee Social Media
Kewaunee Social Media https://www.linkedin.com/company/kewaunee- scientific-corp./posts/ https://www.facebook.com/KewauneeLabs/ https://www.linkedin.com/company/everhutch/ https://www.facebook.com/everhutch Kewaunee Scientific Corporation | NASDAQ: KEQU 21
Slide 22: FY 2022 Q1 Earnings Release – September 8, 2021
FY 2022 Q1 Earnings Release – September 8, 2021, following the market close Kewaunee Scientific Corporation | NASDAQ: KEQU 22
Slide 23: Thank You and Questions
Thank You and Questions Kewaunee Scientific Corporation | NASDAQ: KEQU 23
Slide 24: Appendix
Appendix Kewaunee Scientific Corporation | NASDAQ: KEQU 24
Slide 25: Non-GAAP Reconciliations
Non-GAAP Reconciliations Kewaunee Scientific Corporation Kewaunee Scientific Corporation Annual Shareholder Meeting | August 25, 2021 Appendix: Non-GAAP Measures (Dollars in Thousands) The following unaudited tables reconcile Net Earnings to EBITDA, by Segment and Consolidated EBITDA and Segment EBI
Kewaunee Scientific — Shareholder Meeting (August 2021) on 6ix